Cordyceps Sunshine Biotech Holdings (RAJAF) Long-Term Deferred Tax (2020 - 2023)

Cordyceps Sunshine Biotech Holdings' Long-Term Deferred Tax history runs 4 years deep, the most recent figure standing at $44667.0 for Q4 2023.

• In Q4 2023, Long-Term Deferred Tax fell 96.78% year-over-year to $44667.0; the TTM figure through Dec 2023 stood at $44667.0 (down 96.78% YoY), while the FY2023 annual figure was $44667.0, down 96.78% from the prior year.
• Long-Term Deferred Tax was $44667.0 for Q4 2023 at Cordyceps Sunshine Biotech Holdings, down from $1.4 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $1.6 million in Q4 2021 to a low of $44667.0 in Q4 2023.
• Historically, Long-Term Deferred Tax has averaged $1.1 million across 4 years, with a median of $1.3 million in 2020.
• The sharpest annual moves came in 2021 and 2023: Long-Term Deferred Tax rose 22.23% in 2021, then sank 96.78% in 2023.
• A 4-year view of Long-Term Deferred Tax shows it stood at $1.3 million in 2020, then grew by 22.23% to $1.6 million in 2021, then retreated by 11.76% to $1.4 million in 2022, then tumbled by 96.78% to $44667.0 in 2023.
• The last three Long-Term Deferred Tax figures came in at $44667.0 (Q4 2023), $1.4 million (Q4 2022), and $1.6 million (Q4 2021), per Business Quant data.